Besides, in the study by Lishmanov et al., the PTH level in CKD patients (stages 3 and 4) was associated with an increased incidence of cardiovascular events independent of calcium–phosphorous level, kidney function, previous history of vascular disease, and serum 25(OH) D levels [227]. This evidence concerns the gene PTH and chronic kidney disease.